|
|
|
|
LEADER |
02059nam a22003855i 4500 |
001 |
000294419 |
005 |
20211015102321.0 |
007 |
cr nn 008mamaa |
008 |
130723s2013 sz | s |||| 0|eng d |
020 |
|
|
|a 9783034806640
|
024 |
7 |
|
|a 10.1007/978-3-0348-0664-0
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
100 |
1 |
|
|a Maximov, Philipp Y.
|e author.
|
245 |
1 |
0 |
|a Tamoxifen :
|b Pioneering Medicine in Breast Cancer /
|c by Philipp Y. Maximov, Russell E. McDaniel, V. Craig Jordan.
|
250 |
|
|
|a 1st ed. 2013.
|
260 |
# |
# |
|a Basel :
|b Springer Basel :
|b Imprint: Springer,
|c 2013.
|
300 |
|
|
|a XXII, 202 p. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Milestones in Drug Therapy,
|
505 |
0 |
|
|a Discovery and Pharmacology of Nonsteroidal Estrogens and Antiestrogens -- Tamoxifen Goes Forward Alone -- Metabolites of Tamoxifen as the Basis of Drug Development -- Adjuvant Therapy – The Breakthrough -- The Wisconsin Story in the 1980’s: Discovery of Target Site Specific Estrogen Action -- Carcinogenesis and Tamoxifen -- Chemoprevention: Cinderella waiting for the ball -- Tamoxifen and Raloxifene head to head: The STAR TRIAL -- Acquired resistance to Tamoxifen: back to the beginning -- The legacy of Tamoxifen -- Appendix: Four decades of discovery in breast cancer research and treatment – an interview with V. Craig Jordan by Marc Poirot -- Selected Awards that Recognize the Contribution of Tamoxifen and Raloxifene to Medicine.
|
650 |
|
0 |
|a Cancer research.
|
650 |
|
0 |
|a Oncology .
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Endocrinology .
|
650 |
1 |
4 |
|a Cancer Research.
|
650 |
2 |
4 |
|a Oncology.
|
650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
650 |
2 |
4 |
|a Endocrinology.
|
700 |
1 |
|
|a McDaniel, Russell E.
|e author.
|
700 |
1 |
|
|a Jordan, V. Craig.
|e author.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|